Literature DB >> 23649288

Prostate cancer: active surveillance in African American men.

Judd W Moul1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23649288     DOI： 10.1038/nrurol.2013.97

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

Review 2.  The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis.

Authors:  Isaac J Powell
Journal:  Arch Esp Urol       Date:  2011-10       Impact factor: 0.436

3.  Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting.

Authors:  J W Moul; T H Douglas; W F McCarthy; D G McLeod
Journal:  J Urol       Date:  1996-05       Impact factor: 7.450

4.  Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients.

Authors:  Viacheslav Iremashvili; Murugesan Manoharan; Soum D Lokeshwar; Daniel L Rosenberg; David Pan; Mark S Soloway
Journal:  BJU Int       Date:  2012-06-15       Impact factor: 5.588

5.  A multi-institutional evaluation of active surveillance for low risk prostate cancer.

Authors:  Scott E Eggener; Alex Mueller; Ryan K Berglund; Raj Ayyathurai; Cindy Soloway; Mark S Soloway; Robert Abouassaly; Eric A Klein; Steven J Jones; Chris Zappavigna; Larry Goldenberg; Peter T Scardino; James A Eastham; Bertrand Guillonneau
Journal:  J Urol       Date:  2013-01       Impact factor: 7.450

6.  Age-specific reference ranges for serum prostate-specific antigen in black men.

Authors:  T O Morgan; S J Jacobsen; W F McCarthy; D J Jacobson; D G McLeod; J W Moul
Journal:  N Engl J Med       Date:  1996-08-01       Impact factor: 91.245

Review 7.  Active surveillance for prostate cancer: a systematic review of the literature.

Authors:  Marc A Dall'Era; Peter C Albertsen; Christopher Bangma; Peter R Carroll; H Ballentine Carter; Matthew R Cooperberg; Stephen J Freedland; Laurence H Klotz; Christopher Parker; Mark S Soloway
Journal:  Eur Urol       Date:  2012-06-07       Impact factor: 20.096

8.  Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center.

Authors:  M R Abern; M R Bassett; M Tsivian; L L Bañez; T J Polascik; M N Ferrandino; C N Robertson; S J Freedland; J W Moul
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-10-16       Impact factor: 5.554

9.  Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance.

Authors:  Yun-Sok Ha; Amirali Salmasi; Michael Karellas; Eric A Singer; Jeong Hyun Kim; Misop Han; Alan W Partin; Wun-Jae Kim; Dong Hyeon Lee; Isaac Yi Kim
Journal:  Urology       Date:  2013-03-07       Impact factor: 2.649

10.  Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

Authors:  J W Moul; I A Sesterhenn; R R Connelly; T Douglas; S Srivastava; F K Mostofi; D G McLeod
Journal:  JAMA       Date:  1995-10-25       Impact factor: 56.272
  10 in total
  1 in total

Review 1.  Active surveillance for prostate cancer: current evidence and contemporary state of practice.

Authors:  Jeffrey J Tosoian; H Ballentine Carter; Abbey Lepor; Stacy Loeb
Journal:  Nat Rev Urol       Date:  2016-03-08       Impact factor: 14.432
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.